Lightning Round OT: Pfizer, Vale and More

Bristol-Meyers Squibb : Cramer likes the dividend but said the growth has been lacking. He recommended the company sell itself to Merck or Pfizer . Still he’s bullish on BMY.

Gafisa : Cramer’s bullish on Gafisa. He said he was time to go back to another Brazilian play, Vale .

Questions for Cramer?

Questions, comments, suggestions for the Mad Money website?